Stocksigma LogoStocksigma Logo

Lord’s Mark Industries Investor Meet Presentation Highlights

Lord’s Mark Industries targets rapid growth driven by its IVD/MedTech, Renalyx dialysis, and solar verticals, forecasting revenue to surge from ₹710 Cr in

Lord’s Mark Industries Investor Meet Presentation Highlights

Lords Mark Industries Ltd · Investor Presentation · 15 Sept 2026, 11:50 pm

Lord’s Mark Industries Investor Meet Presentation Highlights Lord’s Mark Industries targets rapid growth driven by its IVD/MedTech, Renalyx dialysis, and solar verticals, forecasting revenue to surge from ₹710 Cr in FY25 to ₹2,638 Cr in FY29 (~25.2% CAGR) with EBITDA margins expanding to 15.1%. The company holds a ₹2,000 Cr secured clean energy order book within a ₹3,000+ Cr pipeline. Key strategic catalysts include a ₹500 Cr FPO/preferential allotment and NSE listing in FY27, an IVD/MedTech demerger by FY28, and a targeted $3 billion group valuation by 2029.

Original exchange filing (PDF)

More announcements from Lords Mark Industries Ltd

All Lords Mark Industries Ltd announcements